TORONTO, June 19, 2019 (GLOBE NEWSWIRE) -- Cronos
Group Inc. (CRON.TO) (CRON.TO) (âCronos Groupâ or the
âCompanyâ) reports that at its Annual Meeting of
Shareholders on June 19, 2019 there were 610 shareholders voting in
person or by proxy holding in total 261,290,314 common shares,
representing 78.2% of the total number of common shares
outstanding.
Each of the directors listed as a nominee in the management proxy circular dated May 8, 2019 was elected to serve as a director of the Company until the next annual meeting. The results of the vote for the election of directors are as follows:
Name of Director | Number of Shares Voted For* |
Percentage of Shares Voted For |
Number of Shares Withheld from Voting* |
Percentage of Shares Withheld from Voting |
Jason Adler | 183,807,372 | 99.75% | 459,017 | 0.25% |
Kevin C. Crosthwaite, Jr. | 178,988,142 | 97.14% | 5,278,247 | 2.86% |
Bronwen Evans | 183,745,229 | 99.72% | 521,160 | 0.28% |
Murray R. Garnick | 180,124,077 | 97.75% | 4,142,312 | 2.25% |
Bruce A. Gates | 180,134,640 | 97.76% | 4,131,749 | 2.24% |
Michael Gorenstein | 179,747,903 | 97.55% | 4,518,486 | 2.45% |
James Rudyk | 180,525,486 | 97.97% | 3,740,903 | 2.03% |
* As the vote for each motion was taken by ballot, the number of votes disclosed reflects the votes submitted by ballot at the meeting.
About Cronos Group
Cronos Group is an innovative global cannabinoid company with
international production and distribution across five
continents. Cronos Group is committed to building disruptive
intellectual property by advancing cannabis
research, technology and product development. With a
passion to responsibly elevate the consumer
experience, Cronos Group is building an iconic brand
portfolio. Cronos Groupâs portfolio includes PEACE
NATURALSâ¢, a global health and wellness
platform, and two adult-use brands, COVE⢠and Spinachâ¢.
To learn more about Cronos Group and its brands,
please visit: www.thecronosgroup.com; www.peacenaturals.com; www.covecannabis.ca; www.spinachcannabis.com.
Forward-looking statements
This news release contains âforward-looking informationâ and
âforward-looking statementsâ within the meaning of applicable
Canadian and U.S. securities laws. All information contained
herein that is not clearly historical in nature may constitute
forward-looking information. In some cases, forward-looking
statements can be identified by words or phrases such as âmayâ,
âwillâ, âexpectâ, âplanâ, âanticipateâ, âintendâ, âpotentialâ,
âestimateâ, âbelieveâ or the negative of these terms, or other
similar expressions intended to identify forward-looking
statements. Some of the forward-looking statements contained in
this press release include the Companyâs intention to build an
international iconic brand portfolio and develop disruptive
intellectual property. Forward-looking statements are necessarily
based upon a number of estimates and assumptions that, while
considered reasonable by management, are inherently subject to
significant business, economic and competitive risks, uncertainties
and contingencies that may cause actual financial results,
performance or achievements to be materially different from the
estimated future results, performance or achievements expressed or
implied by those forward-looking statements and the forward-looking
statements are not guarantees of future performance. A discussion
of some of the material risks applicable to the Company can be
found in the Companyâs current Managementâs Discussion and Analysis
and Annual Information Form, both of which have been filed on SEDAR
and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. The forward-looking
information included in this news release is made as of the date of
this news release and, except as required by law, Cronos
Group disclaims any obligation to update or revise any
forward-looking statements. Readers are cautioned not to put undue
reliance on these forward-looking statements.
For further information please
contact:
Anna Shlimak
Investor Relations
Tel: (416) 504-0004
[email protected]